BellBrook

Transcreener OAS FP Assay

CHF 0.00
In stock
BBL-3027-1K1000 assaysCHF 1'234.00
BBL-3027-10K10000 assaysCHF 6'497.00
BBL-3027-100K10 x 10000 assaysINQ
More Information
Product Details
Synonyms 2'-5'-Oligoadenylate Synthase
Product Type Kit
Properties
Application Set Compound Screening
Crossreactivity All
Quantity

1000 assays/384wells (BBL-3027-1K)

10000 assays/384wells (BBL-3027-10K)

Note: The exact number of assays depends on enzyme reaction conditions.

Sensitivity Excellent data quality (Z’ ≥ 0.7) and signal (≥100 mP polarization shift) for determining OAS activity by measuring 2-5A production.
Detection Type Fluorescent polarization
Kit Contains

AMP2/GMP2 Antibody, AMP2/GMP2 Alexa Fluor® 633 Tracer, 2-5A–AMP Coupling Enzyme, ATP, AMP, dsRNA, OAS Buffer 10X

Note:  The plates are not included, please see manual for material not provided but necessary for assay.

Other Product Data

Click here for Complete Information from the Original Manufacturer
Our product description may differ slightly from the original manufacturers product datasheet.


Assay Features

Measure Enzymatic Activity of OAS1, OAS2, or OAS3. Designed as in homogenous, one-step format to enable reproducibility. Robust Assay Z’ > 0.7 under initial velocity conditions. Far-red fluorescent readouts minimize compound interference. A safe, non-radioactive method.

Declaration Manufactured by BellBrook Labs.
Shipping and Handling
Shipping DRY ICE
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
Manual Download PDF
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

The Transcreener® high throughput screening (HTS) assay platform overcomes the need for time-consuming, one-off assay development for individual members within a group transfer enzyme family by utilizing a single set of assay reagents that detect an invariant product. The generic nature of the Transcreener® HTS Assay platform eliminates delays involved in assay development for new HTS targets and greatly simplifies compound and inhibitor profiling across multiple target families. Transcreener assays have been validated with major HTS instruments to determine the optimal filters and settings for maximal assay performance. Application notes with all important details are available. The Transcreener OAS Assay measures the 2-5A produced by OAS1 (also known as 2'-5'-oligoadenylate synthetase 1) OAS2, or OAS3. By measuring the production of OAS researchers can effectively determine the activity of OAS enzymes. The assay provides a powerful tool to screen compound libraries for OAS modulators to help find new therapeutics for a variety of different conditions including autoimmune diseases. 

The Role of OAS1 In Innate Immunity: Double-stranded RNA enters the cell from viral infection. As the first line of defense in the innate immune system, OAS1 is activated by viral double-stranded RNA. Upon activation, OAS1 synthesizes 2-5A from ATP which in turn activates RNase L. The result of this signaling event cleaves both viral and host RNA and in turn inhibition of protein synthesis in the cell, thus ending the replication of invading RNA viruses. Mutation or inadvertent stimulation can produce autoimmune conditions by activating the pathway inconsistently even while not in the presence of viral invaders.


© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.